Decreased MAP2 was also recently observed in bipolar disorder via proteomic analysis of the postsynaptic density (Föcking et al., 2016)—though not, to date, at the whole homogenate level—while it fails to exhibit change at the mRNA level by RNA sequencing (Gandal et al., 2018). The gene discussed is MAP2; the disease is bipolar disorder.